Why the study?
Antidepressants are commonly prescribed and clear national guidelines exist for treatment sequencing, but trends and variation across English primary care required examination.
Antidepressant prescribing in English primary care has more than tripled over two decades, with substantial unwarranted variation between practices in the prescribing of specific drugs like dosulepin.
Answers are grounded in this paper and cite their sources.
Marked variation in antidepressant prescribing across practices supports targeted audits; leaves open drivers of sustained growth and guideline adherence.
BACKGROUND: Antidepressants are commonly prescribed. There are clear national guidelines in relation to treatment sequencing. This study examines trends and variation in antidepressant prescribing across English primary care. AIM: Retrospective longitudinal study using national and practice-level data on antidepressant items prescribed per year (1998-2018) and per month (2010-2019). METHOD: Class- and drug-specific proportions were calculated at national and practice levels. Descriptive statistics were generated, percentile charts and maps were plotted, and logistic regression analysis was conducted. RESULTS: Antidepressant prescriptions more than tripled between 1998 and 2018, from 377 items per 1000 population to 1266 per 1000. MAOI prescribing fell substantially, from 0.7% of all antidepressant items in 1998 to 0.1% in 2018. There was marked variation between practices in past year prescribing of paroxetine (median practice proportion [MPP] = 1.7%, interdecile range [IDR] = 2.6%) and dosulepin (MPP = 0.7%, IDR = 1.8%), but less for trimipramine (MPP = 0%, IDR = 0.2%). CONCLUSION: Rapid growth and substantial variation in antidepressant prescribing behaviour was found between practices. The causes could be explored using mixed-methods research. Interventions to reduce prescribing of specific antidepressants, such as dosulepin, could include review prompts, alerts at the time of prescribing, and clinician feedback through tools like OpenPrescribing.net.
No takes yet. Share an insight, caveat, or question.
Bogowicz et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: